Russian harm reduction NGO fights foreign agent status – Interview with Alexei Lahov

The criteria on what constitutes a 'foreign agent' is so vague that it can include journalism or criticism of domestic health policy.

News Alerts March 3, 2022

Civil society supports government proposal to reform drug laws in the Czech Republic

Reforms would provide a legal framework to implement safer consumption sites, drug checking and expanded decriminalisation.

News Alerts May 26, 2021

Will Colombia restart aerial coca spraying? | Drugreporter Café

A discussion on the critical oversights the Colombian government will make should they reimplement the aerial spraying of glyphosate.

News Alerts April 19, 2021

Romania: No funding for needle exchange

Fundamental harm reduction services are forced to downsize dramatically in the absence of government or donor support.

News Alerts March 2, 2021

What can we learn from the COVID-19 pandemic?

5 November 2020 08:30-10:30

Webinar

In this EHRN webinar, the lessons learnt from COVID-19 and the way forward in responding to the pandemic will be examined from diverse group of perspectives.

Events 22 October 2020

The oldest harm reduction organisation in Bulgaria shut down

The Bulgarian government has refused to take responsibility for the country's harm reduction response since the Global Fund's departure.

News Alerts September 1, 2020

The European Union should not fight drugs but reduce harms

The new EU drugs strategy subsumes social and health responses to a predominantly law-and-order approach.

News Alerts August 5, 2020

Reflections for a new EU drugs strategy

Ensuring the next Drugs Strategy is implemented is crucial to ensure the EU’s credibility and the health of its citizens.

News Alerts March 20, 2020

Cannabis legalisation has arrived in Europe: Civil society should not be silent

As the legal regulation of cannabis becomes progressively imminent, civil society must have a say in the way it is implemented.

News Alerts February 21, 2020

The unchallenged rule of designer drugs in Hungary

The NPS market is thriving and research suggests prevalence might be underestimated.

News Alerts January 3, 2020

Video content

Subscribe to our newsletters